Corcept Therapeutics submits FDA application for relacorilant to treat Cushing’s syndrome

Corcept Therapeutics Incorporated has taken a significant step in addressing the unmet needs of patients with hypercortisolism, commonly known as Cushing’s syndrome. The biopharmaceutical company ... Read More